We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Optibrium Expands UK Head Office With New Facilities on Cambridge Innovation Park
Product News

Optibrium Expands UK Head Office With New Facilities on Cambridge Innovation Park

Optibrium Expands UK Head Office With New Facilities on Cambridge Innovation Park
Product News

Optibrium Expands UK Head Office With New Facilities on Cambridge Innovation Park


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Optibrium Expands UK Head Office With New Facilities on Cambridge Innovation Park"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Optibrium™, a developer of software for drug discovery, has announced the expansion of its UK headquarters with a move to larger office premises on Cambridge Innovation Park North. The new facilities accommodate Optibrium's accelerated growth and ongoing recruitment efforts to support the continued success and development of the company's innovative technology focused on improving the efficiency and productivity of the drug discovery process.


Optibrium's new headquarters, located in one of the UK's leading technology hubs, provide new offices, meeting rooms, social areas and on-site leisure activities to promote employee well-being. The premises will facilitate recruitment opportunities created by the company's ongoing expansion and commercial development, such as for C++ Software Engineers, DevOps Engineers and Researchers.


Over 170 organisations worldwide, including leading pharmaceutical companies, deploy Optibrium's computational drug discovery technology in their research programs. Its lead product, StarDrop™, is a comprehensive suite of integrated software for small molecule design, optimisation, and data analysis that enhances the speed and productivity of the drug discovery process. Cerella™, Optibrium's proven artificial intelligence platform, empowers project teams with valuable insights from complex drug discovery data to maximise the success of preclinical discovery projects.


Headquartered in Cambridge, UK, Optibrium also has offices in Boston and San Francisco, USA.


Optibrium's CEO Matt Segall said, "The space will enable us to accommodate new employees and provide the exciting opportunity to accelerate our growth plans. We look forward to welcoming new, highly talented software specialists and scientists dedicated to delivering our best-in-class in silico technologies and Artificial Intelligence platforms."

  

Advertisement